ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Charging Use Fee for Compounds In Repository

August 12, 1983

HHS, MB, OSTP Urge President To Veto Biomedical Research Authorization; Senate Pushes FTE Levels

October 25, 1985

In Brief: Grand Jury To Consider Charges Against N.M. Community Based Cancer Program Staff Members

January 4, 1980

NCI Restructures AIDS Effort; New Research Thrusts Recommended

October 5, 1984

States Join Suit Alleging Amgen Offered Illegal Kickback To Doctors For Aranesp

November 6, 2009

NCCS Networker Volume 9 Issue 4, Winter 1995

January 12, 1995